FDA Grants Genentech’s Polivy Accelerated Approval for People with Previously Treated Aggressive Lymphoma Read more
Hoth Therapeutics to Begin Production of BioLexa Therapeutic for Upcoming Toxicology and Clinical Trials Read more
Rick Thompson CEO at Findacure invitation to SMI’s Orphan Drugs & Rare Diseases Conference 2019 Read more
CStone and Bayer announce global collaboration to evaluate PD-L1 monoclonal antibody CS1001 in combination with regorafenib Read more
Bayer and Arvinas to Collaborate on Human PROTAC Therapies and Launch a Separate Joint Venture to Develop Agricultural PROTAC Applications Read more
Celgene and Acceleron Announce FDA Accepts Luspatercept Biologics License Application in Myelodysplastic Syndromes and Beta-Thalassemia Read more
Vertex Expands into New Disease Areas and Enhances Gene Editing Capabilities Through Expanded Collaboration with CRISPR Therapeutics and Acquisition of Exonics Therapeutics Read more